Alpha 2.0
Login Register
» Articles » PMID: 26482377

Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury Via CXCR4

Overview
Journal Cardiovasc Drugs Ther
Specialties Cardiology & Vascular Diseases
Pharmacology
Date 2015 Oct 21
PMID 26482377
Citations 11
Authors
A Malik
D I Bromage
Z He
L Candilio
A Hamarneh
S Taferner
S M Davidson
D M Yellon
Affiliations
Soon will be listed here.
Citing Articles

Platelet-enriched microRNAs as novel biomarkers in atherosclerotic and cardiovascular disease patients.

Masoudikabir P, Shirazy M, Taghizadeh F, Gheydari M, Hamidpour M ARYA Atheroscler. 2024; 20(4):47-67.

PMID: 39717424 PMC: 11663285. DOI: 10.48305/arya.2024.41664.2898.

Associations between static and dynamic changes of platelet counts and in-hospital mortality in critical patients with acute heart failure.

Wang L, Liu T, Zhu Z, Wang B, Lu Z, Pan Y Sci Rep. 2024; 14(1):9147.

PMID: 38644461 PMC: 11033279. DOI: 10.1038/s41598-024-59892-w.

Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response.

Pearce L, Davidson S, Yellon D Basic Res Cardiol. 2021; 116(1):12.

PMID: 33629195 PMC: 7904035. DOI: 10.1007/s00395-021-00852-0.

SDF-1α promotes repair of myocardial ischemic necrosis zones in rats.

Cai X, Zhu Z, Zhang Y, Tian X Int J Clin Exp Pathol. 2020; 12(6):1956-1967.

PMID: 31934018 PMC: 6949651.

Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury.

Bromage D, Taferner S, He Z, Ziff O, Yellon D, Davidson S J Mol Cell Cardiol. 2019; 128:187-197.

PMID: 30738798 PMC: 6408335. DOI: 10.1016/j.yjmcc.2019.02.002.

References
1.
Keeley E, Boura J, Grines C . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351):13-20. DOI: 10.1016/S0140-6736(03)12113-7. View
2.
Davidson S, Selvaraj P, He D, Boi-Doku C, Yellon R, Vicencio J . Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol. 2013; 108(5):377. DOI: 10.1007/s00395-013-0377-6. View
3.
Bromage D, Davidson S, Yellon D . Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther. 2014; 143(3):305-15. PMC: 4127789. DOI: 10.1016/j.pharmthera.2014.03.009. View
4.
Huang C, Gu H, Zhang W, Manukyan M, Shou W, Wang M . SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol. 2011; 301(4):H1496-505. PMC: 3197365. DOI: 10.1152/ajpheart.00365.2011. View
5.
Hu X, Dai S, Wu W, Tan W, Zhu X, Mu J . Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation. 2007; 116(6):654-63. PMC: 3640445. DOI: 10.1161/CIRCULATIONAHA.106.672451. View